The Patent Finder

Xigen S.A.

Also on record
Records under this name other than patents Xigen S.A. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Xigen S.A.

PatentTitleStatus Expires Confidence
US 9,006,185Use of cell-permeable peptide inhibitors of the JNK signal transduction pathway for the treatment of various diseases
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,150,618Use of cell-permeable peptide inhibitors of the JNK signal transduction pathway for the treatment of chronic or non-chronic inflammatory eye diseases
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,180,159Use of cell-permeable peptide inhibitors of the JNK signal transduction pathway for the treatment of chronic or non-chronic inflammatory digestive diseases
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,981,052Novel JNK Inhibitor Molecules
Formerly held
In force
 · High confidence
In forceHigh confidence
US 9,290,538Cell-Permeable Peptide Inhibitors of the JNK Signal Transduction Pathway
Formerly held
Term ended
Term ended Sep 12, 2026 · High confidence
Term endedTerm ended Sep 12, 2026High confidence
US 10,023,615Efficient Transport into White Blood Cells
Formerly held
Lapsed on the fee record
Ended Jul 17, 2026 · High confidence
Lapsed on the fee recordEnded Jul 17, 2026High confidence
US 8,748,395Cell-Permeable Peptide Inhibitors of the JNK Signal Transduction Pathway
Lapsed on the fee record
Ended Jun 10, 2026 · High confidence
Lapsed on the fee recordEnded Jun 10, 2026High confidence
US 8,236,924Cell-permeable peptide inhibitors of the JNK signal transduction pathway
Term ended
Term ended Feb 27, 2026 · From the USPTO record
Term endedTerm ended Feb 27, 2026From the USPTO record
US 8,080,517Cell-Permeable Peptide Inhibitors of the JNK Signal Transduction Pathway
Formerly held
Term ended
Term ended Sep 12, 2025 · High confidence
Term endedTerm ended Sep 12, 2025High confidence
US 9,624,267JNK inhibitor molecules
Formerly held
Lapsed on the fee record
Ended Apr 18, 2025 · From the USPTO record
Lapsed on the fee recordEnded Apr 18, 2025From the USPTO record
10 of 25 patents shown.
Pro members see all 25.
Pro members: see all 25 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited